External validation of prognostic models for overall survival (OS) in patients (pts) with advanced cancer (UC) treated with cisplatin-based chemotherapy.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: National Institutes of Health, National Cancer Institute, Georgetown University, Memorial Sloan Kettering Cancer Center, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, University of California, San Francisco, Duke Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2963907965